REKA.TA TLV
Rekah Pharmaceutical Industry Ltd.
1W: -0.1%
1M: +12.5%
3M: +11.9%
YTD: -1.1%
1Y: -2.2%
3Y: -29.5%
5Y: -50.0%
₪1,145.00 ($3.80)
-31.00 (-2.64%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$447M
-7.7% ▼
5Y CAGR: +4.0%
Total Liabilities
$285M
-13.3% ▼
5Y CAGR: +6.1%
Shareholders Equity
$162M
+4.1% ▲
5Y CAGR: +0.9%
Cash & Investments
$7M
-63.5% ▼
5Y CAGR: -22.7%
Total Debt
$134M
-25.0% ▼
5Y CAGR: -1.4%
Net Debt
$127M
-20.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $37M | $19M | $20M | $19M | $7M |
| Short-Term Investments | $40K | $39K | $80K | $39K | $39K |
| Cash & ST Investments | $37M | $19M | $20M | $19M | $7M |
| Net Receivables | $88M | $107M | $121M | $118M | $129M |
| Inventory | $98M | $90M | $92M | $97M | $82M |
| Other Current Assets | $2M | $3M | $7M | $18M | $6M |
| Total Current Assets | $227M | $222M | $243M | $251M | $229M |
| Property, Plant & Equip. | $182M | $177M | $163M | $155M | $140M |
| Goodwill & Intangibles | $4M | $33M | $36M | $67M | $61M |
| Long-Term Investments | $2M | $0 | $0 | $1M | $1M |
| Other Non-Current Assets | $45K | $5K | $5K | $11M | $39K |
| Total Non-Current Assets | $192M | $215M | $205M | $233M | $218M |
| Total Assets | $420M | $437M | $448M | $485M | $447M |
| — Liabilities — | |||||
| Accounts Payable | $64M | $61M | $88M | $90M | $97M |
| Short-Term Debt | $27M | $19M | $20M | $30M | $30M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $9M | $9M | $21M | $28M | $20M |
| Total Current Liabilities | $108M | $99M | $139M | $144M | $158M |
| Long-Term Debt | $91M | $101M | $92M | $149M | $64M |
| Other Non-Current Liab. | $11M | $20M | $15M | $30M | $25M |
| Total Non-Current Liabilities | $146M | $165M | $147M | $185M | $127M |
| Total Liabilities | $254M | $264M | $286M | $329M | $285M |
| — Equity — | |||||
| Common Stock | $14M | $14M | $14M | $14M | $14M |
| Retained Earnings | $26M | $33M | $21M | $15M | $21M |
| Accumulated OCI | $91K | $536K | $933K | $1M | $988K |
| Total Stockholders Equity | $166M | $173M | $162M | $156M | $162M |
| Total Liabilities & Equity | $420M | $437M | $448M | $485M | $447M |
| — Key Metrics — | |||||
| Total Debt | $166M | $166M | $154M | $179M | $134M |
| Net Debt | $129M | $147M | $134M | $160M | $127M |
| Total Investments | $2M | $39K | $80K | $1M | $1M |